HeartSciences Inc. (HSCS) Revenue History
Annual and quarterly revenue from 2020 to present
HSCS Revenue Over Time (2020–2025)
HSCS Revenue Growth History
1 of 5 years with positive growth- FY2020 revenue growth
- N/A
- FY2021 revenue growth
- -60.1%
- FY2022 revenue growth
- -43.9%
- FY2023 revenue growth
- -64.2%
- FY2024 revenue growth
- +261.2%
- FY2025 revenue growth
- -76.6%
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $0 | — |
| Q2 2026 | $2K | — |
| Q1 2026 | $2K | — |
| Q4 2025 | $4K | — |
| Q3 2025 | $0 | -100.0% |
| Q2 2025 | $0 | -100.0% |
| Q1 2025 | $0 | — |
| Q4 2024 | $0 | — |
Multi-year avg. share of annual revenue by fiscal quarter
HSCS Revenue Analysis (2020–2025)
Current Revenue & Growth
As of June 28, 2026, HeartSciences Inc. (HSCS) generated trailing twelve-month (TTM) revenue of $8,669. The most recent quarter (Q3 2026) recorded $0 in revenue, down 100.0% sequentially.
Historical Growth Trajectory
HSCS's 5-year compound annual growth rate (CAGR) stands at -41.6%, indicating revenue contraction over this period. The 3-year CAGR of -32.9% exceeds the 5-year average, indicating an acceleration in the most recent period. HeartSciences Inc.'s highest annual revenue of $64,182 was recorded in 2020.
Peer Comparison
Compared to Healthcare sector peers — including IDXX (+13.1% YoY), IRTC (+27.4% YoY), and AORT (+17.6% YoY). Compare HSCS vs IDXX →
HSCS Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| HSCSCurrent | $8,669 | - | -41.6% | -192013.1% | |
 IDXX | $4.3B | +13.1% | +9.7% | 31.6% | |
 IRTC | $747M | +27.4% | +23.0% | -4.9% | |
 AORT | $441M | +17.6% | +11.8% | 6.1% | |
 HOLX | $4.1B | +2.2% | +1.7% | 17.4% |
HSCS Historical Revenue Data (2020–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $4K | -76.6% | $-125,485 | -2884.7% | $-8,352,571 | -192013.1% |
| 2024 | $19K | +261.2% | $-82,614 | -444.2% | $-6,305,770 | -33902.0% |
| 2023 | $5K | -64.2% | $-24,561 | -476.9% | $-6,112,964 | -118698.3% |
| 2022 | $14K | -43.9% | $-20,083 | -139.7% | $-4,709,399 | -32765.6% |
| 2021 | $26K | -60.1% | $-18,672 | -72.9% | $-2,568,128 | -10030.2% |
| 2020 | $64K | - | $-46,105 | -71.8% | $-3,818,184 | -5949.0% |
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
6+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
HSCS — Frequently Asked Questions
Quick answers to the most common questions about buying HSCS stock.
Is HSCS's revenue growth accelerating or slowing?
HSCS TTM revenue: $8669.00. YoY growth: N/A. 5-year CAGR: -41.6%.
What is HSCS's revenue history from 2020 to 2026?
HeartSciences Inc. (HSCS) revenue history spans 2020 to 2026. TTM revenue as of 2026 is $8669.00, growing at N/A YoY. The 5-year CAGR is -41.6%. Complete annual and quarterly revenue figures are available on this page, including gross profit, operating income, and margin trends.
What is HSCS's long-term revenue growth rate (CAGR)?
HeartSciences Inc.'s 5-year revenue CAGR of -41.6% reflects the variable nature of its business expansion. As of 2026, the current YoY growth rate of N/A is in line with this long-term average. CAGR is the most reliable measure of sustained revenue momentum for HSCS.
Why does HSCS's quarterly revenue fluctuate?
HSCS quarterly revenue can fluctuate significantly between periods. A quarter-over-quarter (QoQ) change does not always indicate a trend; comparing the same quarter year-over-year (YoY) is a more reliable signal for underlying growth. HeartSciences Inc.'s revenue data from 2020 to 2026 shows full historical quarterly detail on this page.
How is HSCS's revenue distributed by segment?
HSCS reports revenue broken down by product line and geographic region. The segment breakdown on this page shows which business units contribute the most to total revenue as of the latest fiscal year. Concentration in a single segment above 50% indicates category dependence, while a diversified mix signals more resilient revenue streams.
How does HSCS's revenue compare to industry peers?
HeartSciences Inc. (HSCS) with TTM revenue of $8669.00 and N/A YoY growth can be benchmarked against sector peers using the comparison table on this page. Revenue growth relative to peers indicates market share gains or losses. The peer section shows TTM revenue, YoY growth, and operating margin for direct comparisons.